Halabi S - Search Results

1

Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.

Moorman PG, Calingaert B, Palmieri RT, Iversen ES, Bentley RC, Halabi S, Berchuck A, Schildkraut JM. Moorman PG, et al. Among authors: halabi s. Am J Epidemiol. 2008 May 1;167(9):1059-69. doi: 10.1093/aje/kwn006. Epub 2008 Feb 25. Am J Epidemiol. 2008. PMID: 18303003 Free PMC article.

2

Identification of women at increased risk for breast cancer in a population-based screening program.

Bondy ML, Vogel VG, Halabi S, Lustbader ED. Bondy ML, et al. Among authors: halabi s. Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):143-7. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1306097

3

Prognostic factors in early-onset epithelial ovarian cancer: a population-based study.

Schildkraut JM, Halabi S, Bastos E, Marchbanks PA, McDonald JA, Berchuck A. Schildkraut JM, et al. Among authors: halabi s. Obstet Gynecol. 2000 Jan;95(1):119-27. doi: 10.1016/s0029-7844(99)00535-9. Obstet Gynecol. 2000. PMID: 10636514

4

Age at natural menopause and the risk of epithelial ovarian cancer.

Schildkraut JM, Cooper GS, Halabi S, Calingaert B, Hartge P, Whittemore AS. Schildkraut JM, et al. Among authors: halabi s. Obstet Gynecol. 2001 Jul;98(1):85-90. doi: 10.1016/s0029-7844(01)01388-6. Obstet Gynecol. 2001. PMID: 11430962 Review.

5

Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States).

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Vine MF, Berchuck A. Moorman PG, et al. Among authors: halabi s. Cancer Causes Control. 2002 Nov;13(9):807-11. doi: 10.1023/a:1020678100977. Cancer Causes Control. 2002. PMID: 12462545

6

No relationship between ovarian cancer risk and progesterone receptor gene polymorphism in a population-based, case-control study in North Carolina.

Lancaster JM, Wenham RM, Halabi S, Calingaert B, Marks JR, Moorman PG, Bentley RC, Berchuck A, Schildkraut JM. Lancaster JM, et al. Among authors: halabi s. Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):226-7. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12646513 No abstract available.

7

Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.

Berchuck A, Schildkraut JM, Wenham RM, Calingaert B, Ali S, Henriott A, Halabi S, Rodriguez GC, Gertig D, Purdie DM, Kelemen L, Spurdle AB, Marks J, Chenevix-Trench G. Berchuck A, et al. Among authors: halabi s. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2141-7. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598772

8

Antidepressant medication use [corrected] and risk of ovarian cancer.

Moorman PG, Berchuck A, Calingaert B, Halabi S, Schildkraut JM. Moorman PG, et al. Among authors: halabi s. Obstet Gynecol. 2005 Apr;105(4):725-30. doi: 10.1097/01.AOG.0000157113.98061.eb. Obstet Gynecol. 2005. PMID: 15802397

9

Transforming growth factor beta receptor I polyalanine repeat polymorphism does not increase ovarian cancer risk.

Spillman MA, Schildkraut JM, Halabi S, Moorman P, Calingaert B, Bentley RC, Marks JR, Murphy S, Berchuck A. Spillman MA, et al. Among authors: halabi s. Gynecol Oncol. 2005 May;97(2):543-9. doi: 10.1016/j.ygyno.2005.01.025. Gynecol Oncol. 2005. PMID: 15863158

10

Menopausal hormones and risk of ovarian cancer.

Moorman PG, Schildkraut JM, Calingaert B, Halabi S, Berchuck A. Moorman PG, et al. Among authors: halabi s. Am J Obstet Gynecol. 2005 Jul;193(1):76-82. doi: 10.1016/j.ajog.2004.11.013. Am J Obstet Gynecol. 2005. PMID: 16021062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

569 results

Search Page

Filters